U.S. Bancorp Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

U.S. Bancorp heeft totale activa van $686.5B en een totaal eigen vermogen van $59.3B. De totale stortingen zijn $521.1B |number_shorten( $366.6B. Het verdient een netto rentemarge van 2.9%. Er is voldoende voorziening voor slechte leningen, die momenteel 0.5% van de totale leningen bedragen. Contant geld en kortetermijninvesteringen zijn $77.1B.

Belangrijke informatie

11.6x

Verhouding activa / eigen vermogen

2.9%

Nettorentemarge

Totaal deposito's	US$521.13b
Verhouding leningen/deposito's	Passend
Slechte leningen	0.5%
Voorziening voor dubieuze leningen	Voldoende
Huidige ratio	Laag
Geldmiddelen en kasequivalenten	US$77.05b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

U.S. Bancorp: I'm Buying This Undervalued Stock That Just Raised Its Dividend

Oct 14

U.S. Bancorp: Share Repurchase Plan, Dovish Fed Give Compelling Arguments To Buy

Sep 20

U.S. Bancorp: Excessive Premium To Tangible Equity, Growing Loan Loss Risks, And Precarious Deposits

Mar 15

Aristotle Capital - U.S. Bancorp: An Attractive Return Profile At Discount To Intrinsic Value

Mar 02

U.S. Bancorp: Two Ways To Earn Good Income

Jan 29

U.S. Bancorp: Buy The Dip Opportunity (Technical Analysis)

Jan 22

U.S. Bancorp Remains A Good Income Play

Jan 09

U.S. Bancorp: A Great Time To Exit

Dec 19

Finding Diamonds In The Rough: Uncovering Dividend Gems

Dec 15

U.S. Bancorp: Balance Sheet Flexibility Creates Opportunity

Nov 29

U.S. Bancorp Q3: Growing CRE Headwinds (Rating Downgrade)

Oct 25

U.S. Bancorp: Why The Common Is Better Than The Preferreds Despite Their Higher Yield

Oct 19

U.S. Bancorp's 6.2% Yield: A Very Attractive Buy Ahead Of Q3

Oct 06

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Activa niveau: De Vermogen/vermogensverhouding ( 11.6 x) USB is gematigd.

Voorziening voor slechte leningen: USB heeft een voldoende voorziening voor slechte leningen ( 418 %).

Laag risico verplichtingen: 83% van de verplichtingen van USB bestaan voornamelijk uit laag risico financieringsbronnen.

Leenniveau: USB heeft een passend niveau van Leningen/activa-ratio ( 53% ).

Laag risico deposito's: De Leningen-depositoverhouding ( 70% ) van USB } is passend.

Niveau van slechte leningen: USB heeft een passend niveau van slechte leningen ( 0.5 %).

U.S. Bancorp Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

U.S. Bancorp Announces Management Changes

U.S. Bancorp Announces Structural Changes for Payments Business

Vice Chairman of Payment Services recently sold US$1.7m worth of stock

Vice Chairman of Payment Services notifies of intention to sell stock

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

U.S. Bancorp: I'm Buying This Undervalued Stock That Just Raised Its Dividend

U.S. Bancorp to Report Q3, 2024 Results on Oct 16, 2024

U.S. Bancorp: Share Repurchase Plan, Dovish Fed Give Compelling Arguments To Buy

Second quarter dividend of US$0.50 announced

U.S. Bancorp (NYSE:USB) announces an Equity Buyback for $5,000 million worth of its shares.

U.S. Bank Unveils Two New U.S. Bank Smartly Products

U.S. Bancorp: Get Out Before The Fed Pivot

Second quarter 2024 earnings: EPS exceeds analyst expectations

Aleem Gillani Joins U.S. Bancorp Board of Directors

U.S. Bancorp Stock: Multiple Red Flags Make Me Downgrade To Hold

U.S. Bancorp Plans to Increase Quarterly Common Stock Dividend for the Fourth Quarter of 2024

U.S. Bancorp Announces Executive Changes

U.S. Bancorp to Report Q2, 2024 Results on Jul 17, 2024

First quarter dividend of US$0.49 announced

U.S. Bancorp Announces Quarterly Dividend, Payable on July 15, 2024

U.S. Bancorp Series A Preferred: A Good Source Of Income

U.S. Bancorp Announces New Leaders for its WCIB business

U.S. Bancorp Appoints Gunjan Kedia as President

First quarter 2024 earnings: Revenues and EPS in line with analyst expectations

U.S. Bancorp: Headwinds Persist

First quarter 2024 earnings released: EPS: US$0.85 (vs US$1.04 in 1Q 2023)

U.S. Bancorp Stock: An Attractive Income Pick Ahead Of Q1 2024 Earnings

U.S. Bancorp to Report Q1, 2024 Results on Apr 17, 2024

Upcoming dividend of US$0.49 per share

Fourth quarter dividend of US$0.49 announced

U.S. Bancorp: Excessive Premium To Tangible Equity, Growing Loan Loss Risks, And Precarious Deposits

U.S. Bancorp Declares Regular Quarterly Dividend, Payable on April 15, 2024

U.S. Bancorp Appoints Bill Mulvihill as Head for Loan Capital Markets

U.S. Bancorp, Annual General Meeting, Apr 16, 2024

Aristotle Capital - U.S. Bancorp: An Attractive Return Profile At Discount To Intrinsic Value

Full year 2023 earnings: EPS misses analyst expectations

Chairman notifies of intention to sell stock

Insider notifies of intention to sell stock

U.S. Bancorp: Two Ways To Earn Good Income

U.S. Bancorp: Buy The Dip Opportunity (Technical Analysis)

Full year 2023 earnings: EPS misses analyst expectations

Price target increased by 7.0% to US$48.32

U.S. Bancorp Remains A Good Income Play

Upcoming dividend of US$0.49 per share at 4.6% yield

U.S. Bancorp: A Great Time To Exit

Key Executive recently sold US$1.0m worth of stock

Finding Diamonds In The Rough: Uncovering Dividend Gems

U.S. Bancorp Declares Regular Quarterly Dividend, Payable on January 16, 2024

U.S. Bancorp: Balance Sheet Flexibility Creates Opportunity

U.S. Bancorp Q3: Growing CRE Headwinds (Rating Downgrade)

Third quarter 2023 earnings: EPS misses analyst expectations

U.S. Bancorp Provides Earnings Guidance for the Fourth Quarter 2023

U.S. Bancorp: Why The Common Is Better Than The Preferreds Despite Their Higher Yield

U.S. Bancorp's 6.2% Yield: A Very Attractive Buy Ahead Of Q3

U.S. Bank Names Ariel Meyerstein as Head of ESG Program Office

U.S. Bancorp to Report Q3, 2023 Results on Oct 18, 2023

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse financiële instellingen

Ontdek gezonde bedrijven